FORTREA HOLDINGS INC (FTRE) Stock Price & Overview

NASDAQ:FTRE • US34965K1079

Current stock price

9.63 USD
+0.12 (+1.26%)
At close:
9.63 USD
0 (0%)
Pre-Market:

The current stock price of FTRE is 9.63 USD. Today FTRE is up by 1.26%. In the past month the price increased by 7.6%. In the past year, price increased by 85.91%.

FTRE Key Statistics

52-Week Range3.97 - 18.67
Current FTRE stock price positioned within its 52-week range.
1-Month Range8.55 - 10.39
Current FTRE stock price positioned within its 1-month range.
Market Cap
900.405M
P/E
22.93
Fwd P/E
12.09
EPS (TTM)
0.42
Dividend Yield
N/A

FTRE Stock Performance

Today
+1.26%
1 Week
+2.23%
1 Month
+7.60%
3 Months
-44.62%
Longer-term
6 Months -0.47%
1 Year +85.91%
2 Years -73.68%
3 Years N/A
5 Years N/A
10 Years N/A

FTRE Stock Chart

FORTREA HOLDINGS INC / FTRE Daily stock chart

FTRE Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to FTRE. When comparing the yearly performance of all stocks, FTRE is one of the better performing stocks in the market, outperforming 74.65% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FTRE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to FTRE. FTRE has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FTRE Earnings

On February 26, 2026 FTRE reported an EPS of 0.09 and a revenue of 660.50M. The company missed EPS expectations (-44.92% surprise) and missed revenue expectations (-2.66% surprise).

Next Earnings DateMay 11, 2026
Last Earnings DateFeb 26, 2026
PeriodQ4 / 2025
EPS Reported$0.09
Revenue Reported660.5M
EPS Surprise -44.92%
Revenue Surprise -2.66%

FTRE Forecast & Estimates

17 analysts have analysed FTRE and the average price target is 14.79 USD. This implies a price increase of 53.58% is expected in the next year compared to the current price of 9.63.

For the next year, analysts expect an EPS growth of 89.59% and a revenue growth -4.64% for FTRE


Analysts
Analysts75.29
Price Target14.79 (53.58%)
EPS Next Y89.59%
Revenue Next Year-4.64%

FTRE Groups

Sector & Classification

FTRE Financial Highlights

Over the last trailing twelve months FTRE reported a non-GAAP Earnings per Share(EPS) of 0.42. The EPS increased by 23.53% compared to the year before.


Income Statements
Revenue(TTM)2.72B
Net Income(TTM)-986.20M
Industry RankSector Rank
PM (TTM) N/A
ROA -36.31%
ROE -175.01%
Debt/Equity 1.86
Chartmill High Growth Momentum
EPS Q2Q%-50%
Sales Q2Q%-5.24%
EPS 1Y (TTM)23.53%
Revenue 1Y (TTM)1%

FTRE Ownership

Ownership
Inst Owners102.96%
Shares93.50M
Float92.95M
Ins Owners0.33%
Short Float %11.59%
Short Ratio6.28

About FTRE

Company Profile

FTRE logo image Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. The company is headquartered in Durham, North Carolina and currently employs 14,300 full-time employees. The company went IPO on 2023-06-16. The firm is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The firm offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. The company provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The firm manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The firm has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Company Info

IPO: 2023-06-16

FORTREA HOLDINGS INC

8 Moore Drive

Durham NORTH CAROLINA US

Employees: 14500

FTRE Company Website

Phone: 13026365400

FORTREA HOLDINGS INC / FTRE FAQ

What does FORTREA HOLDINGS INC do?

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. The company is headquartered in Durham, North Carolina and currently employs 14,300 full-time employees. The company went IPO on 2023-06-16. The firm is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The firm offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. The company provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The firm manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The firm has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.


What is the current price of FTRE stock?

The current stock price of FTRE is 9.63 USD. The price increased by 1.26% in the last trading session.


Does FORTREA HOLDINGS INC pay dividends?

FTRE does not pay a dividend.


What is the ChartMill technical and fundamental rating of FTRE stock?

FTRE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Which stock exchange lists FTRE stock?

FTRE stock is listed on the Nasdaq exchange.


What is the market capitalization of FTRE stock?

FORTREA HOLDINGS INC (FTRE) has a market capitalization of 900.41M USD. This makes FTRE a Small Cap stock.


What is the outstanding short interest for FORTREA HOLDINGS INC?

The outstanding short interest for FORTREA HOLDINGS INC (FTRE) is 11.59% of its float.